144 related articles for article (PubMed ID: 31830018)
41. Availability of Long-Acting Reversible Contraception in Kansas Health Departments.
Evans T; Ramaswamy M; Satterwhite CL
J Rural Health; 2018 Mar; 34(2):132-137. PubMed ID: 28397971
[TBL] [Abstract][Full Text] [Related]
42. Barriers to Uptake of Postpartum Long-Acting Reversible Contraception: Qualitative Study of the Perspectives of Ugandan Health Workers and Potential Clients.
Willcox M; King E; Fall E; Mubangizi V; Nkalubo J; Natukunda S; Nahabwe H; Goodhart C; Graffy J
Stud Fam Plann; 2019 Jun; 50(2):159-178. PubMed ID: 30963601
[TBL] [Abstract][Full Text] [Related]
43. Women's awareness of long-acting, reversible contraceptive methods (LARCs) in community family planning clinics and general practice.
Mansour D; Rosales C; Cox M
Eur J Contracept Reprod Health Care; 2008 Dec; 13(4):396-9. PubMed ID: 19117255
[TBL] [Abstract][Full Text] [Related]
44. The Tupange Project in Kenya: A Multifaceted Approach to Increasing Use of Long-Acting Reversible Contraceptives.
Muthamia M; Owino K; Nyachae P; Kilonzo M; Kamau M; Otai J; Kabue M; Keyonzo N
Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S44-59. PubMed ID: 27540124
[TBL] [Abstract][Full Text] [Related]
45. 'Everyone's talking Jadelle': the experiences and attitudes of service providers regarding the use of the contraceptive implant, Jadelle in young people in New Zealand.
Sandle M; Tuohy P
N Z Med J; 2017 Apr; 130(1454):40-46. PubMed ID: 28449015
[TBL] [Abstract][Full Text] [Related]
46. Profile of long-acting reversible contraception users in Europe.
Haimovich S
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):187-95. PubMed ID: 19565416
[TBL] [Abstract][Full Text] [Related]
47. The Mayer Hashi Large-Scale Program to Increase Use of Long-Acting Reversible Contraceptives and Permanent Methods in Bangladesh: Explaining the Disappointing Results. An Outcome and Process Evaluation.
Rahman M; Haider MM; Curtis SL; Lance PM
Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S122-39. PubMed ID: 27540119
[TBL] [Abstract][Full Text] [Related]
48. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
49. Does body mass index or weight perception affect contraceptive use?
Bhuva K; Kraschnewski JL; Lehman EB; Chuang CH
Contraception; 2017 Jan; 95(1):59-64. PubMed ID: 27621045
[TBL] [Abstract][Full Text] [Related]
50. Consenting to invasive contraceptives: an ethical analysis of adolescent decision-making authority for long-acting reversible contraception.
Behmer Hansen RT; Arora KS
J Med Ethics; 2018 Sep; 44(9):585-588. PubMed ID: 29903853
[TBL] [Abstract][Full Text] [Related]
51. Midwives' experiences and views of giving postpartum contraceptive advice and providing long-acting reversible contraception: a qualitative study.
McCance K; Cameron S
J Fam Plann Reprod Health Care; 2014 Jul; 40(3):177-83. PubMed ID: 24500869
[TBL] [Abstract][Full Text] [Related]
52. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
53. Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.
Garrett CC; Keogh LA; Kavanagh A; Tomnay J; Hocking JS
BMC Womens Health; 2015 Sep; 15():72. PubMed ID: 26359250
[TBL] [Abstract][Full Text] [Related]
54. Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial longitudinal follow-up protocol.
Mazza D; Amos N; Watson CJ; McGeechan K; Haas M; Peipert JF; Lucke J; Taft A; McNamee K; Black KI
BMJ Open; 2020 Sep; 10(9):e035895. PubMed ID: 32963063
[TBL] [Abstract][Full Text] [Related]
55. Leveraging long acting reversible contraceptives to achieve FP2020 commitments in sub-Saharan Africa: The potential of implants.
Thanel K; Garfinkel D; Riley C; Esch K; Girma W; Kebede T; Kasongo G; Afolabi K; Kalamar A; Thurston S; Longfield K; Bertrand J; Shaw B;
PLoS One; 2018; 13(4):e0195228. PubMed ID: 29630607
[TBL] [Abstract][Full Text] [Related]
56. Contraception in US servicewomen: emerging knowledge, considerations, and needs.
Harrington LA; Shaw KA; Shaw JG
Curr Opin Obstet Gynecol; 2017 Dec; 29(6):431-436. PubMed ID: 28915159
[TBL] [Abstract][Full Text] [Related]
57. Personalized contraceptive assistance and uptake of long-acting, reversible contraceptives by postpartum women: a randomized, controlled trial.
Simmons KB; Edelman AB; Li H; Yanit KE; Jensen JT
Contraception; 2013 Jul; 88(1):45-51. PubMed ID: 23218851
[TBL] [Abstract][Full Text] [Related]
58. Uptake and adherence to long-acting reversible contraception post-abortion.
Rose SB; Lawton BA; Brown SA
Contraception; 2010 Oct; 82(4):345-53. PubMed ID: 20851228
[TBL] [Abstract][Full Text] [Related]
59. [Long-acting reversible contraception].
Raccah-Tebeka B; Plu-Bureau G
Rev Prat; 2018 Apr; 68(4):387-391. PubMed ID: 30869384
[TBL] [Abstract][Full Text] [Related]
60. A Review of Long-Acting Reversible Contraception Methods and Barriers to Their Use.
Baron MM; Potter B; Schrager S
WMJ; 2018 Oct; 117(4):156-159. PubMed ID: 30407765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
